Skip to main content
OSCOTECInc. logo

OSCOTECInc. — Investor Relations & Filings

Ticker · 039200 ISIN · KR7039200001 KO Manufacturing
Open in API
Filings indexed 271 across all filing types
Latest filing 2024-10-21 Report Publication Anno…
Country KR South Korea
Listing KO 039200

About OSCOTECInc.

https://oscotec.com/

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal notice announcing the scheduling of an Investor Relations (IR) meeting (기업설명회). It provides details such as the date, time, location, purpose, and target audience for the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a regulatory filing announcement regarding an IR event.
2024-10-21 Korean
투자판단관련주요경영사항 (유한양행의 얀센바이오테크 기술이전 마일스톤 분배)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) system titled 'Investment Judgment Related Major Management Matters'. It details a specific financial event regarding the receipt of milestone payments from a technology transfer agreement between Yuhan Corporation and Janssen Biotech. Since this is a specific corporate announcement regarding financial inflows and business developments that does not fit into categories like earnings releases, dividends, or M&A, it falls under the general regulatory filing category.
2024-09-11 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for the company '오스코텍' (OSCOTEC Inc.) covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial information, business operations, management discussions, and shareholding data, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details changes in share ownership by major shareholders (Kim Jung-kun and special related parties) of Oscotec. In the context of global financial reporting, this falls under the 'Major Shareholding Notification' category, as it tracks significant ownership thresholds and changes in control.
2024-06-28 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '오스코텍' (Oscotec) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial information, business operations, management discussions, and capital structure data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting (기업설명회). It provides details such as the date, time, location, target audience, and purpose of the meeting. Since this is an announcement of an upcoming event rather than the presentation materials themselves, and it serves as a regulatory notification of an IR event, it falls under the category of Regulatory Filings (RNS) as it does not fit the specific criteria for an Investor Presentation (IP) or other report types.
2024-04-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.